Data in Brief (Sep 2015)
Data for comparative proteomics analysis of the antitumor effect of CIGB-552 peptide in HT-29 colon adenocarcinoma cells
- Teresa Núñez de Villavicencio-Díaz,
- Yassel Ramos Gómez,
- Brizaida Oliva Argüelles,
- Julio R. Fernández Masso,
- Arielis Rodríguez-Ulloa,
- Yiliam Cruz García,
- Osmany Guirola-Cruz,
- Yasset Perez-Riverol,
- Luis Javier González,
- Inés Tiscornia,
- Sabina Victoria,
- Mariela Bollati-Fogolín,
- Vladimir Besada Pérez,
- Maribel Guerra Vallespi
Affiliations
- Teresa Núñez de Villavicencio-Díaz
- Department of Systems Biology, Center for Genetic Engineering and Biotechnology, Cuba
- Yassel Ramos Gómez
- Department of Systems Biology, Center for Genetic Engineering and Biotechnology, Cuba
- Brizaida Oliva Argüelles
- Pharmaceuticals Department, Center for Genetic Engineering and Biotechnology, Cuba
- Julio R. Fernández Masso
- Department of Systems Biology, Center for Genetic Engineering and Biotechnology, Cuba
- Arielis Rodríguez-Ulloa
- Department of Systems Biology, Center for Genetic Engineering and Biotechnology, Cuba
- Yiliam Cruz García
- Department of Preclinical Studies, National Institute of Oncology and Radiobiology of Cuba, Cuba
- Osmany Guirola-Cruz
- Department of Systems Biology, Center for Genetic Engineering and Biotechnology, Cuba
- Yasset Perez-Riverol
- European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge, UK
- Luis Javier González
- Department of Systems Biology, Center for Genetic Engineering and Biotechnology, Cuba
- Inés Tiscornia
- Cell Biology Unit, Institut Pasteur of Montevideo, Uruguay
- Sabina Victoria
- Cell Biology Unit, Institut Pasteur of Montevideo, Uruguay
- Mariela Bollati-Fogolín
- Cell Biology Unit, Institut Pasteur of Montevideo, Uruguay
- Vladimir Besada Pérez
- Department of Systems Biology, Center for Genetic Engineering and Biotechnology, Cuba
- Maribel Guerra Vallespi
- Pharmaceuticals Department, Center for Genetic Engineering and Biotechnology, Cuba
- DOI
- https://doi.org/10.1016/j.dib.2015.06.024
- Journal volume & issue
-
Vol. 4,
no. C
pp. 468 – 473
Abstract
CIGB-552 is a second generation antitumor peptide that displays potent cytotoxicity in lung and colon cancer cells. The nuclear subproteome of HT-29 colon adenocarcinoma cells treated with CIGB-552 peptide was identified and analyzed [1]. This data article provides supporting evidence for the above analysis.
Keywords
